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W‘I ABSTRACT 
Methods are provided for minimizing damage to blood in a 
blood pump wherein the blood pump comprises a plurality 
of pump components that may affect blood damage such as 
clearance between pump blades and housing. number of 
impeller blades, rounded or flat blade edges. variations in 
entrance angles of blades. impeller length. and the like. The 
process comprises selecting a plurality of pump components 
believed to affect blood damage such as those listed here- 
inbefore. Construction variations for each of the plurality of 
pump components are then selected. The pump components 
and variations are preferably listed in a matrix for easy 
visual comparison of test results. Blood is circulated through 
a pump configuration to test each variation of each pump 
component. After each test, total blood damage is deter- 
mined for the blood pump. Preferably each pump compo- 
nent variation is tested at least three t imes to provide 
statistical results and check consistency of results. The least 
hemolytic variation for each pump component is preferably 
selected as an optimized component. If no statistical differ- 
ence as to blood damage is produced for a variation of a 
pump component, then the variation that provides prefmed 
hydrodynamic performance is selected. To compare the 
variation of pump components such as impeller and stator 
blade geometries, the preferred embodiment of the invention 
uses a stereolithography technique for realizing complex 
shapes within a short time period. 
1 Claim, 9 Drawing Sheets 
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METHOD FOR REDUCING PUMPING 
DAMAGE TO BLOOD 
This is a division of application Ser. No. 08/153,595, 
filed Nov. 10, 1993, now U.S. Pat. No. 5,527,159. 
mELD OF THE INVENTION 
The invention described herein was made in the perfor- 
mance of work under a NASA contract and is subject to the 
provisions of Section 305 of the National Aeronautics and 
Space Act of 1958. Public Law 85-568 (72 Stat. 435; 42 
U.S.C. 2457). 
1. Technical Field 
The present invention relates generally to rotary blood 
pumps. More specifically, the present invention relates to an 
axial flow ventricle assist blood pump. 
2. Background of the Invention 
Ventricle assist devices are frequently used to boost blood 
circulation to assist a heart which st i l l  functions but is not 
pumping sufficient blood for adequate circulation. Rotary 
pumps are often the preferred type of pump for use as a 
ventricle assist device compared to other types of pumps 
which may use pistons, rollers, diaphragms, or compliance 
chambers. This is partially because rotary pumps may be 
manufactured at a relatively low cost and are typically less 
complex than other types of pumps. Other types of blood 
pumps may cost up to $50,000 per unit and. due to financial 
limitations. are therefore not available for use upon the large 
population which could benefit from such pumps. Rotary 
blood pumps are increasingly used not only for ventricular 
assist applications, but also for cardiopulmonary bypass 
procedures and percutaneous cardiopulmonary support 
applications in emergency cases. 
Clinical uses of rotary pumps are conventionally limited 
to a few days due to shoacomings of these pumps. A 
noncomprehensive list of such problems or shortcomings 
would include the following: (1) blood damage which may 
occur when blood comes into contact with rotor bearings, (2) 
the need for bearing purge systems which may require 
percutaneous (through the skin) saline solution pump 
systems, (3) bearing seizure resulting from the considerable 
thrust and torque loads, or from dried blood sticking on the 
bearing surfaces, (4) problems of blood damage (hemolysis) 
and blood clotting (thrombosis) caused by relative rotational 
movement of the components of the pump, ( 5 )  pump and 
control size and shape limitations necessary for implantation 
or convenient mobility. (6) weight limitations for implanta- 
tion to avoid tearing of implant grafts due to inertia of 
sudden movement, (7) dirsculty in  coordinating and opti- 
mizing the many pump design parameters which may affect 
hemolysis, (8) high power consumption that requires a larger 
power supply, (9) motor inefficiency caused by a large air 
gap between motor windings and drive magnets. (10) heat 
flow from the device to the body, (1 1) complex Hall Effect 
sensors/electronics for rotary control, (12) the substantial 
desire for minimizing percutaneous (through the skin) 
insertions, including support lines and tubes, and (13) large 
pump and related hose internal volume which may cause an 
initial shock when filled with saline solution while starting 
Although a significant amount of effort has been applied 
to solving the problems associated with rotary pumps. there 
is st i l l  a great demand for a safe, reliable. and durable blood 
pump that may be used for longer term applications. The 
estimated need for a simple and long term ventricle assist 
device (VAD) is presently projected at between 50,000 and 
100,OOO patients per year in the United States alone. 
The following patents describe attempts made to solve 
problems associated with rotary blood pumps, including 
ventricle assist devices. 
the pump. 
U.S. Pat. No. 4,625,712 to R. K. Wampler discloses a 
full-flow cardiac assist device for cariogenic shock patients 
which may be inserted into the heart through the femoral 
artery and driven via a flexible cable from an external power 
5 source. A catheter attached to the pump supplies the pump 
bearings with a blood-compatible purge fluid to prevent 
thrombus formation and the introduction of blood elements 
between rotating and statioxmy elements. Due to the very 
small diameter of the pump, rotational speeds on the order 
of 10.000 to 20,000 rpm are used to produce a blood flow of 
U.S. Pat. No. 4,957.504 to W. M. Charduck discloses an 
implantable blood pump for providing either continuous or 
pulsatile blood flow to the heart. The pump includes a stator 
having a cylindrical opening, an annular array of electro- 
magnets disposed in a circle about the stator concentric with 
the cylindrical opening, a bearing carried by the stator and 
extending across the cylindrical opening, and a rotor sup  
ported by the bearing. The rotor is in the form of an 
Archimedes screw and has a permanent magnet in its 
20 periphery which lies in the same plane as the circular array 
of electromagnets for being driven in stepper motor fashion. 
U.S. Pat. No. 4,944,722 to J. W. Carriker discloses a 
percutaneously insertable intravascular axial flow blood 
pump with a rotor extension and drive cable fitting designed 
25 so that the thrust bearing surfaces of the purge seal and cable 
fitting can be preloaded. 
US. Pat. No. 4,817,586 to R. K. Wampler discloses an 
intravascular flow blood pump having blood exit apertures 
in the cylindrical outside wall of the pump housing between 
U.S. Pat. No. 4,908,012 to Moise et at. discloses an 
implantable ventricular assist system having a high-speed 
axial flow blood pump. The pump includes it blood tube in 
which the pump rotor and stator are coaxially contained. and 
35 a motor stator surrounding the blood duct. A permanent 
magnet motor rotor is integral with the pump rotor. Purge 
fluid for the hydrodynamic bearings of the device and power 
for the motor are preferably percutaneously introduced from 
extra-corporeal sources worn by the patient. 
U.S. Pat. No. 4,779,614 to J. C. Moise discloses an 
implantable axial flow blood pump which includes a mag- 
netically suspended rotor of a relative small diameter dis- 
posed without bearings in a cylindrical blood conduit. 
Neodymium-boron-iron rotor magnets allow a substantial 
gap between the static motor armature and the rotor. Mag- 
45 netically permeable strips in opposite ends of the pump 
stator blades transmit to Hall sensors the variations in an 
annular magnetic field surrounding the rotor and adjacent 
the ends of the pump stator blades. 
U.S. Pat. No. 5,049,134 to Golding et al. discloses a seal 
50 free centrifugal impeller supported in a pump housing by 
fluid bearings through which a blood flow passageway is 
U.S. Pat. No. 4382,199 to M. S. Isacson discloses a 
hydrodynamic bearing system for use with a left ventricle 
55 assist device. The bearings are formed by the fluid in  the gap 
between the rotor and the stator. 
U.S. Pat. No. 4,135,253 to Reich et al. discloses a 
centrifugal blood pump provided with a magnetic drive 
system which permits a synchronous magnetic coupling 
60 with a separate power unit disposed immediately adjacent 
the pump housing but outside of the skin surface. The pump 
has a single moving part which includes the combination of 
an impeller connected to a magnetic drive rotor. The mag- 
netic drive system floats on a fluid surface of saline solution. 
U.S. Pat. No. 4,507,048 to J. Belenger discloses a cen- 
trifugal blood pump with a bell-shaped housing having a 
suction inlet at the apex and a tangential outlet adjacent the 
lo about four liters per minute. 
30 the rotor blades and the rotor journal bearing. 
4o 
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base. A conical rotator is driven by spaced permanent 
magnets embedded in the base of the rotator and an exter- 
nally generated rotating magnetic field. 
U.S. Pat. No. 4,688,998 to Olsen et at. discloses a pump 
with a magnetically suspended and magnetically rotated 
impeller. The impeller may be configured for axial flow with 
a hollow, cylindrical-type impeller with impeller vanes on 
the internal surface thereof. The impeller includes a plurality 
of internally embedded, permanent magnets that cooperate 
with eledromagnets for drive and position control of the 
impeller. 
US. Pat. No. 4,763,032 to Bramm et at. discloses a 
magnetic rotor bearing for suspending a rotor for an axial or 
radial-centrifugal blood pump in a contact-free manner, and 
comprising a permanent and electromagnetic arrangement. 
U.S. Pat, No. 4.846,152 to Wampler et at. discloses a 
miniature high-speed intravascular blood pump with two 
rows of rotor blades and a single row of stator blades within 
a tubular housing. The first row of blades has no provision 
for a variable pitch, but produces a mixed centrifugal and 
axial flow by increasing hub diameter. The second row of 
blades is axially spaced from the first row, and produces a 
purely axial flow. The stator blades are reverse twisted to 
straighten and slow the blood flow. 
U.S. Pat. No. 4,944.748 to Bramm et at. discloses an 
impeller io a blood pump supported by pgmanent magnets 
on the impeller and pump housing, which are stabilized by 
an electromagnet on the pump housing. The impeller is 
rotated magnetically, and stator coils in the housing are 
supplied with electric currents having a frequency and 
amplitude adjusted in relation to blood pressure at the pump 
inlet. 
U.S. Pat. No. 4.994.078 to R. K Jarvik discloses an 
electrically powered rotary hydrodynamic pump having 
motor windings and laminations disposed radially about an 
annular blood channel, and having a motor rotor disposed 
therein such that an annular blood channel passes through 
the gap between the motor rotor and the windings. 
U.S. Pat. No. 5,055,005 to Kletschka discloses a fluid 
pump with an electromagnetically driven rotary impeller 
levitated by l d z e d  opposed fluid forces. 
In spite of the &ort evidenced by the above patents, there 
remains the need for an improved rotary pump for use as a 
ventricle assist device that is reliable. compact, requires 
limited percutaneous insertions, and produces fewer blood 
damage problems. n o s e  skilled in the art will appreciate the 
features of the present invention which addresses these and 
other problems. 
STAEMEtNT OF THE INVENTION 
The present invention provides a rotary blood pump 
which includes a pump housing defining a blood flow path 
therethrough. A first stator having a fist  stator field winding 
is used to produce a first stator magnetic field. A first rotor 
is mounted within the pump housing for rotation in response 
to the first stator magnetic field The first rotor carries a blade 
thereon to propel blood through the pump housing along the 
blood flow path. At least one magnet is seamed to the first 
rotor and produces a first rotor magnetic field that passes 
through the first stator field winding during rotation of the 
first rotor to thereby induce a back emf within the first stator 
field winding. Back emf sensor circuitry connected to the 
first stator field winding senses back emf produced during 
the rotation of the first rotor within the pump housing. In one 
embodiment of the present invention, at least one magnet is 
implanted in each of a plurality of impeller blades to produce 
rotational movement of the rotor. 
The rotary pump also includes. i n  a preferred 
embodiment, an inducer portion of the rotor having a 
4 
plurality of inducer blades equidistantly disposed about a 
circumference of the rotor with each inducer blade having a 
variable pitch along its axial length. An interconnection 
blade portion connects at least one of the inducer blades to 
5 at least one impeller blade to form a continuous blade 
extending through said inducer and impeller portions of the 
rotor. 
The rotary pump preferably includes a first rotor bearing 
for rotatably supporting the rotor within the pump housing. 
The rotor bearing includes a curved bearing surface fixed 
with respect to the pump housing. The fixed bearing surface 
receives a rotating member having a rotating curved bearing 
surface. The fixed bearing surface and the rotating a w e d  
bearing surface define a bearing chamber which is filled with 
biw.mnpatible material. An object of the present invention 
A further object is to provide an improved control circuit 
for controlling a rotor within the pump in response to a back 
emf produced in stator windings. 
Another object is to provide an improved rotor bearing for 
which cross-linked blood forms a bearing surface and blood 
seal. 
Yet another object of the present invention is to provide a 
method for optimizing pump parameters to reduce blood 
25 hemolysis. 
A feature of the present invention is a reduced air gap 
between permanent magnets on the rotor and the stator 
winding. 
Another feature of the present invention is an impeller 
Another feature of the present invention is a back emf 
integrated circuit for controlling rotor operation. 
An advantage of the present invention is improved rotor 
control. 
Another advantage of the present invention is quantifiably 
reduced damage to blood. 
Yet another advantage of the present invention is an 
elimination of the need for a bearing purge system requiring 
saline canying tubes penetrating through the skin. 
Other objects, features and intended advantages of the 
present invention will be readily apparent by the references 
to the following detailed description in connection with the 
accompanying drawings and claims. 
BRIEF DEScRIpllON OF DRAWINGS 
l5 is to provide an improved rotary blood pump. 
2o 
3o having a variable pitch blade. 
35 
40 
45 
FIG. 1 is an elevational view, partially in section, of a 
rotary blood pump in accord with the present invention; 
FIG. 2 is an end view of a stator showing stator l d ~ -  
tions stacked to form a skewed stator; 
FIG. 2A is an elevational view indicating the skewed path 
of stator field windings through the stator; 
FIG. 3 is an elevational view, partially in section, of an 
alternative embodiment rotary blood pump having distinct 
impeller and inducer blades; 
FIG. 4 is a cross-sectional view of a portion of an impeller 
showing non-radiused blade tips; 
FIG. 5 is a block diagram of a control system including a 
back emf integrated circuit and a microprocessor; 
FIG. 6A is an elevational view, partially in section. of a 
60 ball-socket rotor bearing having a bearing chamber filled 
with bicFcompatible material, 
FIG. 6B is an elevational view, partially in  section, of a 
shaft journal rotor bearing having a bearing chamber filled 
with biecompatible mat-, 
FIG. 6C is an elevational view. partially in section. having 
a rotor bearing washed from increased blood flow caused by 
a bend in the pump housing; 
50 
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FIG. 6D is an elevational view, partially in section, 
showing a rotor beating shaft having blood flow passages 
along the shaft periphery; 
FIG. 6E is a cross-sectional view along line 6Ec6E; 
FIG. 6F is an elevational view, paaially in section. of a 
rotor bearing for supporting the rotor in cantilevered fash- 
ion; 
FIG. 7 is a chart showing optimum pump parameter 
components determined from methods of optimizing pump 
parameters to minimize hemolysis; 
FIG. 8 shows the test matrix of the present invention for 
optimizing pump parameters to minimize hemolysis while 
maximizing pump efficiency; 
FTG. 9 is a graph showing change in inducer blade pitch 
along the axial length of the inducer; and 
FIG. 10 is an elevational view. partially in section, of two 
axially spaced pumps for separate or combined operation in 
accord with the present invention. 
While the invention will be described in connection with 
the presently preferred embodiments, it will be understood 
that it is not intended to limit the invention to these embodi- 
ments. On the contrary, it is intended to cover all 
alternatives. modifications. and equivalents as may be 
included in the spirit of the invention. 
BRlEF DESCRIPTION OF PREFERRED 
EMBODIMENTS 
The present invention describes a rotary blood pump 
which has an improved rotor control system. The rotary 
pump has a pump blade geometry optimized by a method of 
the present invention to provide high pump efficiency while 
minimizing hemolysis and thrombus (hemolysis is defined 
quantitatively hereinafter). The pump requires less than 10 
watts of power to pump 5 literdminute against a pressure 
head of 100 mm Hg. A preferred embodiment of the pump 
weighs 53 grams, has a length of 75 111111. and a diameter of 
25 min. An index of hemolysis of 0.018 g/lOO liters pumped 
has been achieved. although using the method of this 
invention, further reductions are possible. For reference, a 
more standard roller pump has an index of hemolysis of 0.06 
g/lOO liters. Published articles concerning aspects of the 
present invention are hereby incorporated by reference and 
include the following: (1) "In Vitro Performance of the 
BaylorNASA Axial Flow Pump", Artijicial Organs, 1993 
Volume 17. number 7, page 609613; (2) "Development of 
BaylotNASA Axial Flow VAD, Ar@cMl Organs, 1993, 
Volume 17, page 469. 
Referring now to the drawings, and more particularly to 
FIG. 1, there is a shown a rotary blood pump 10 in accord 
with the present invention. Blood pump 10 includes a 
preferably metallic tubular pump housing 12 which is, in a 
preferred embodiment, a straight-sided cylinder. Pump 
housing 12 has a smooth inner bore wall 15 to minimize 
thrombus formation. Pump housing 12 defines a blood flow 
path 13 therethrough in the direction indicated by blood flow 
mows shown in FIG. 1. 
Front and rear clamps 14 and 16. respectively, are used to 
secure flow straightener 18 and diffuser 20 within pump 
housing 12. Pump housing 12 is sufficiently thin-walled so 
that the tightening of clamps 14 and 16 with clamp screws 
22 locally deforms pump housing 12 about flow straightener 
18 and diffuser u) to afEx these components in position. The 
clamps provide a very convenient means of securing the 
rotor assembly. Alternatively, other means for securing these 
components could be used, such as spot welding, fasteners, 
and interference fit. 
Flow straightener 18 serves two basic functions: (1) it 
straightens blood flow to reduce hemolysis while improving 
5 
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pump efficiency, and (2) it provides a support structure for 
front ball-socket bearing assembly 24, as discussed herein- 
after. By straightening the flow of blood as it initially flows 
into the entrance 36 of pump 10. hydraulic efficiency is 
increased. Straightening the blood flow also reduces turbu- 
lence to increase the pump pressure. FIG. 7 lists optimal 
values and permissible pump parameter ranges for the flow 
straightener 18 and the other pump components. 
Flow straightener 18 preferably has four fixed blades 26, 
but could have only two blades. Too many blades impede 
blood flow, while too few blades reduces pump efficiency. 
For purposes of lowering thrombosis, the front edge 28 of 
each blade 26 is sloped from inner housing wall 15 to flow 
straightener hub 32 so that blood trauma by contact with 
blades 26 is minimized. Also to reduce blood trauma, flow 
straightener hub 32 is cylindrical with a round leading 
surface 34. Surface 34 may also be hyperbolical or generally 
bullet-shaped for this purpose. An alternative embodiment 
flow straightener 18a is shown in FIG. 3, and does not have 
the sloping front edge blades. 
The preferred angle of attack of blades 26 is 90", Le.. the 
blades would intersect a plane transverse to cylindrical 
housing 12 at an angle of 90". This reference for the angle 
of attack or pitch of the blades wiU be used throughout this 
specification. 
Flow straightener 18 is preferably metallic. but may also 
be formed of plastic. If formed of plastic and secured in 
place by clamp 14, it is necessary to reinforce flow straight- 
ener 18 with. for instance, metallic supports to prevent 
plastic creep deformation. The plastic meep deformation 
phenomena might otherwise eventually cause flow straight- 
ener 18 to come loose from clamp 14. Reinforcement is also 
necessary with respect to other clamped plastic pump com- 
ponents. 
Diffuser 20 also has two basic purposes: (1) it 
de-accelerates and redirects the outflow at blood flow path 
exit 40 axially to boost pump performance. and (2) it serves 
as a support structure for the rear rotor bearing 42. Diffuser 
20 preferably has from 5 to 8 fixed blades 38, with 6 blades 
being presently preferred. Blades 38 are fixably engaged 
with pump housing 12 after rear clamp 16 is tightened by 
screw 22. 
To perform the function of deacceleration and axial 
redirection of blood flow, each diffuser blade 38 has an 
entrance angle of from about 10" to 25" for slowing the 
blood down, and an outlet angle of from about 80" to 90" for 
redirecting blood flow in an axial direction. Presently pre- 
ferred blade geometry is listed in FIG. 7 and includes an 
entrance angle of 15" and an outlet angle of 90". Tail cone 
44 of diffuser 20 is hyperbolical or generally bullet-shaped 
to reduce turbulence or wake of blood flow from pump 10 
so as to minimize blood damage from such turbulence. 
Somewhat surprisingly, it was found that increasing the 
number of fixed blades tends to decrease hemolysis. 
Rotor 46 is supported for rotary movement with pump 
housing 12 by front and rear bearings 24 and 42, respec- 
tively. Rotor 46 is divided into two portions along its axis 
based on the type and function of the blades disposed 
thereon. Inducer portion 48 is disposed in the front part of 
rotor 46, Le., nearer to the pump inlet 36. Impeller portion 
50 is disposed in the rear part of rotor 46 closer to pump 
outlet 40. It has been found that including an inducer portion 
in an axial flow pump, along with an impeller portion, 
significantly reduces hemolysis. 
FIG. 3 shows an alternative embodiment pump of the 
present invention which provides for two distinct sets of 
axially spaced blades which more clearly distinguish the 
inducer portion of the rotor from the impeller portion of the 
rotor. Corresponding components of pump 10 and loa are 
5,678.306 
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given the same number, with the difference of an "a" sufFur blades is six, but a range from two to six blades provides 
to distinguish the components for comparison purposes as permissible pump efficiency. If impeller 55 included six 
necessary. Areference to one number is therefore a reference axially longer blades, such as longer blade 68, the flow area 
to its corresponding number in th is  specification. unless through impeller portion 50 is restricted to such an extent 
otherwise stated. Where components are substantially dif- that the blades actually begin to block the flow they are 
ferent between the two pump versions, completely new intendedto produce. 
numbers are assigned. In pump 1% inducer portion 48a is Using the method of this invention, it was unexpectedly 
separated from impeller portion 5Oa of rotor 440 by gap 490, discovered that hemolysis does not necessarily innease with 
which is preferably less than 0.10 inches. Inducer blade 52a the number of blades. as anticipated. The alternating long- 
may be tapered (not shown) at forward end 56u so that blade short blade arrangement of the six bladed impeller of the 
5% has a smaller radial length at forward end 564 perhaps lo present invention does not cause hemolysis any more sig- 
even blending into hub 73. However. using the method of nificantly than a two-bladed impeller. In some cases, an 
the present invention, it has been found that a continuous impeller with four long blades may cause more hemolysis 
blade pump has even more reduced levels of hemolysis than than either a two or six bladed impeller. It is possible that the 
the non-continuous blade pump 1Oa. Thus, pump 10 shown degree of hemolysis depends more on the number of long 
in FIG. 1 is the presently preferred embodiment. 15 blades rather than the total number of blades. 
Inducer blades 52 on inducer 53 have a variable pitch FIG. 4 shows a portion of impeller 55 in cross-section to 
along their axial length. RG. 9 shows an inducer blade angle illustrate the substantially flat, non-radiused blade tips 72. It 
profile that plots angle of attack in degrees versus axial has been unexpectedly found, using the method of this 
position on inducer 53 in inches. It was found that the invention, that flat or substantially flat, non-radiused blade 
inducer portion 48 reduced hemolysis by approximately ZJ tips have substantially the same pump response, but do not 
45% from a pump design without the inducer. Hydraulic produce significantly different hemolysis results from 
efficiency was also increased as the rotation speed required rounded or radiused blade tips. It was anticipated that flat 
to pump 5 literdmin of blood at 100 mm Hg. dropped from blade tips would produce higher hemolysis. Because flat 
12.600 rpm to 10.800 rpm. The inducer blades 52 pre-rotate blade tips are less expensive to manufacture in conjunction 
the blood before it enters the main pumping or impeller 54 25 with magnets to be used in the blades as discussed 
to reduce hemolysis. hereinafter, flat blade tips comprise the presently preferred 
Inducer blades 52 also achieve a pumping action that embodiment. Further test results are discussed in greater 
effectively produces a two-stage, increased efficiency pump. detail in the previously noted articles incorporated herein by 
optimum inducer blade geometry for minimal hemolysis reference. 
and maximum pump efficiency is listed for specific parts of 3o FIG. 4 also illustrates a preferred rotor hub 73 with 
inducer blade 52 in the chart of FIG. 7. Thus. the entrance outside diameter 74 compared to the overall outside diam- 
angle of leading end 56 of inducer blade 52 is preferably 10". eter 76 of inducer 53 andor impeller 55. The preferred ratio 
but has a preferred range from about 10" to 20". The shallow is 0.48, although a range of 0.45 to 0.55 permits excellent 
entrance angle effectively engages the blood for movement pump operation. If the hub is smaller than permitted by th is  
without damaging the blood. The pitch of inducer blade 52 range. blood becomes excessively swirled and may tend to 
continues to change along its axial length, and preferably is 35 recirculate within pump 10 in the wrong flow direction to 
about 30" at midpoint 58 of the blade. The tailing end 60 of possibly damage the blood as well as reduce pump &- 
inducer blade 52 preferably has an outer angle of 20". This ciency. If the hub is too large so as to be outside of this range, 
variable pitch is described in FIG. 9, which shows how pitch the hub tends to block flow through the pump 10. 
varies with the axial length of inducer 53. AS well, it k The radial clearance 78 between inducer 53 and/or impel- 
desired that inducer blades have a m P  Of preferably 240" & ler 55 with respect to the pump housing inner wall 15 is 
around rotor 46. The presently preferred overlap of each preferably in the range of about 0.003 inches to 0.015 
of FIG. 7 provides a complete listing of relevant pump invention, it was unexpectedly discovered that smallerradid 
Parameter Values. including preferred ranges Of opmdon. clearances lowered hemolysis. It was expected that smaller 
Outside of these ranges. pump efficiency drops andor blood 45 clearances would produce greater blood damage due to 
damage is more likely to occur. higher sheer stresses on the blood. The presently preferred 
Pump 10 includes an interconnecting blade portion 62 radial clearance 78 is about 0.005 inches. Axial clearances 
which is not included in pump 1Oa. Although the two-stage between components, such as flow straightener 18. rotor 46, 
pump 1Oa produces significantly reduced hemolysis and and diffuser u), are shown in FIG. 7. Axial clearances should 
efiicient pump operation compared to a single stage pump, 50 be within the ranges shown to improve pump efFciency and 
it has been discovered that by interconnecting inducer blades to reduce hemolysis. 
52 with h p d k ~  blades 54 with interconnecting blade In or& to reduce the air gap between stator 80 and 
portion 62, hemolysis may be reduced to even lower levels magnets 82, the magnets are preferably sealingly mounted 
while maintaining efficient pump operahion. within impeller blades 54. Reducing the air gap between the 
Impeller blades 54 on impeller 55 have an entrance angle 55 stator 80 and the magnets 82 increases motor efficiency, 
in leading end region 64 of preferably 20". This may be seen because magnetic flux is not as diffused as in  motor designs 
more clearly in FXG. 3, which has no interconnecting blade with large air gaps. The preferred radial spacing or air gap 
portion 62. The entrance angle preferably smoothly tapers to between magnets 82 and stator 80 is from 0.01 inches to 
an optimum preferred outer angle of 90' at blade tailing end 0.025 inches. Magnets 82 are preferably rare earth magnets 
region 66. The opthum ranges of operation for the entrance because of the higher magnetic flux produced by such 
and outlet angles is given in FIG. 7. magnets. Each magnet 82 is encapsulated in an individual 
Jmpeller blades 54 include axially longer impeller blades. pocket 84 to eliminate corrosion. Because magnets are 
such as longer blade 68, and axially shorter impeller blades. individualized, motor torque and rotor weight can be easily 
such as shorter blade 70. The alternate long and short blade adjusted in the manufactwing stage to provide motors that 
arrangement on impeller 55 accommodates multiple mag- are tailored to the type of pump performance necessary 
netic poles for electric motor operation as discussed 65 without producing excessive pump weight. 
hereinaftex. and st i l l  maintains adequate flow area through Field winding 88 generates a magnetic field to rotate rotor 
impeller 55. Presently, the preferred number of impeller 46. Stator 80 is comprised of individual stator laminations 
bl& over 0 t h  blades is 120" ora 50% overlap. The chart inches. using a test matrix p r  the method of th is  
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86 to eliminate eddy currents that generate heat and reduce component having an “a” sufiix. Control system 100 oper- 
efficiency. Heat flow from pump 10 is directed both into the ates either manually or by micro-control as discussed 
blood stream and into the tissues surrounding pump 10. In subsequently, and may be used for test purposes if desired. 
this way. the blood is not heated in a manner that may Control system 108 applies current to stator windings 88. 
damage the blood and, as well, the surrounding tissues do Refexably stator 80 includes three stator windings 88. Stator 
not have to absorb all the heat. Heat conductive flow paths 80 generates a rotating magnetic field which magnets 82 and 
using thermally conductive material, such as the metal ofthe thus rotor 46 follow to produce motion. The motor stator 
stator or a thermally conductive gel. may be used to provide may be three phase ‘Y” or “Delta” wound. The operation of 
approximately the desired ratio of heat flow to the tissues the brushless D.C. motor of the present invention requires a 
compared to the heat flow to the blood. proper sequence of power to be applied to stator windings 
As illustrated in FIG. 2, stator 80. comprised of individual lo 88. ’ h o  stator Windings 88 have Power applied to them at 
laminations 86, is stacked in a presently preferred skewed any one time. BY sequencing the voltage on and off to the 
manner such that pathways 90 provide a motor winding respective stator Windings 88, a rotahg magnetic field is 
pathway that is offset from the rotor axis 92. The skew of produced. 
laminations 86 may or may not correspond in some manner A preferred embodiment three-phase motor requires a 
with the offset angle or changing offset angle of the row of 15 repetitive sequence of six states to generate a rotathg 
magnets 82. and is not limited to the position shown in FIG. magnetic field, although other commutation schemes could 
2. A skewed stator 80 is also indicated in FIG. 2.4, which be used. The six states are produced by electronic commu- 
shows an offset path from axis 92 for the field windings 88 tation provided by power F.E.T.’s 104. If Motor 1 were 
which travel through stator 80. The skewing angle or offset sequenced through the six electrical states at a controlled 
from the rotor axis is used to optimize performance. The 20 frequency without feedback, its operation would be that of 
skewing angle of stator 80 may be variable ratha than fixed a stepper motor. In such a mode of operation. the motor 
along its length. While skewed stator 80 is the presently rapidly loses its ability to genemte torque as the rpm’s 
preferred embodiment, other factors or combinations of increase. 
factors (e.g. small air gap. magnet dentation, etc.) produce Control system 100 detects back electromotive force or 
excellent pump and motor performance without a skewed 25 back emf to control motor operation. whenever a conductor, 
stator. such as field winding 88, is cut by moving magnetic lines of 
An axial force is produced on rotor 46 during rotation, force, such as are generated by magnets 82, a voltage is 
which can be varied by moving stator 80 axially along pump induced. The voltage will increase with rotor speed. It is 
housing 12. Stator 80 is axially adjustable for th is  purpose, possible to sense this voltage in one of the three stator 
and could be fixed in position during manufacturing for 3o windings 88 because only two of the motor’s windings are 
optimal performance given the number of magnets to be activated at any one time, to determine the rotor 46 position, 
used and given other factors discussed hereinafter. The axial and to activate commutator switches 104. The circuitry is 
force thus produced can be used to offset the thrust created much simpler and more reliable than Hall Effect sensors 
during pumping to reduce the load on the front or rear which have been used in the past. Although a back emf 
bearing assemblies 24 and 42. respectively. The axial p s i -  control is the presently preferred embodiment, a Hall effect 
tioning of stator 80 may also be used to optimize electrical 35 driven commutation scheme could also be used. 
motor efficiency. Back emf integrated circuit 106 provides sensors for 
Referring to FIG. 5, a block diagram of the control system detecting the back emf from lines indicated at 107, and 
100 of the present invention is shown. Note that control Operates commutation switches 104 accordingly. Apresently 
system 100 may operate two motors 1 and 2, such as shown preferred back emf integrated circuit includes a ML4411 
in FIG. 10. For some applications, either for implantation 01 40 motor controller integrated circuit. Each commutation 
for external use. it may be desirable to have two pumps switch F.E.T. is preferably turned all the way on or off for 
connected either in parallel or in series. Thus. control system maximum power efficiency. 
100 can be easily configured for this purpose if desired. In Back emf integrated circuit 106 also provides a start up 
addition. magnets (not shown) may be placed in the inducer mode operation when the back emf is not present or large 
hub to provide a secondary motor in the case of primary 45 enough for detection. From zero to approximately 200 
motor or controller failure. Various other back-up and redun- rpm’s, motor 1 operates in stepper motor fashion as 
dancy configurations may be used. described hereinbefore. Motor speed is controlled with a 
For instance, in an axially spaced pump configuration difference amplifier 108, which may take its speed signal 
shown in FIG. 10, motors 1 and 2 are axially displaced from from either micro-controller 102 or speed adjust pot 110 as 
each other and may be operated separately or in conjunction selected by switch 112. A speed detection signal is available 
with each other as control system 188 regulates power, as from the back emf inkgated circuit 106 for this w s e .  
discussed hereinafter, to axially spaced stators 207 and u)8 Restart circuit 110 and micro-controller 102 monitor 
containing stator windings 210 and 212, respectively. Bail- voltage developed across sense resistor 111 (present prefer- 
socket bearing 203 on modified diffuser 204 rotatably sup ence is about 0.1 ohms) and the frequency signal from back 
ports rotor 205 of motor 2. which is axially spaced from 55 emf integrated Circuit 106 to determine whether motor 1 
rotor 206 of motor 1. DiffUsm 204 acts as a flow straightener should be restarted, Le., due to a sudden increase or decrease 
when independent operation of motor 2 is desired. Control in current or frequency. Switch 113 may be used to select 
system 100 may be used to operate both motors simulta- between use of restart circuit 110, micro-controller 102, or 
neously or to turn one motor on if micro-controller 102 a manual restart switch 114. Controller 102 may be pro- 
senses that another motor has failed. Micro-controller 102 grammed to produce an alarm signal if there are sudden 
may be programmed for pulsatile motor operation or con- 60 changes in power consumption or frequency, as may occur 
tinuous speed motor operation of one or more motors, as if heart strength weakens or improves. To protect the elec- 
desired. tronics from electromagnetic interference (EMl), fenite 
If only one pump is to be used. extra components may be beads 116 are used with wires to an external power supply. 
removed. In FIG. 3. except for micro-controller 102, most The electronics are preferably hermetically sealed in case 
components are duplicated to allow for operation ofthe two 65 118, which is formed of a high mu material to limit EML 
motors. For convenience, reference to corresponding com- Referring now to preferred bearing configuration 
ponents will be made to one number, with the corresponding embodiments, FIG. 6A discloses a presently preferred ball- 
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socket bearing configuration. The bearings are comprised of 
bio-compatible material and, in the presently preferred 
embodiment, are comprised of ceramic material. The ball- 
socket bearing 121 may be configured as shown in FIG. 1, 
or may be otheawise configured. Ball 120 is preferably 
secured by some securing means. such as glue or welding, 
along edge 128. Ball 120 could be molded into one 
component, or split and s e m d  as is known in the art. Ball 
120 has a spherical surface 122 that engages a mating seat 
spherical surface 124. A void or bearing chamber 126 is 1o 
filled with a bio-compatible material to prevent blood from 
coming into this area and stagnating. In a preferred 
embodiment, bearing chamber 126 is left empty and allowed 
to fill with blood. The blood cross-links due to bearing heat 
and takes on a soft, pliable, plastic texture. The cross-linked 
blood may perform to some extent. a bearing surface 15 
function. The cross-linked blood then prevents other blood 
from entering the bearing and stagnating. 
While the ball-socket bearing is the preferred 
configuration, another configurations may be used. Shaft- 
journal bearing 130 provides shaft 132 secured to compo- 20 
nent 134, which may be rotor 46, for rotation with a second 
component l36, which may be diffuser 20. Journal sleeve 
138 has a cylindrical bearing receiving surface 140 for 
engaging the cylindrical shaft bearing surface 142. A bio- 
compatible material in bearing chamber 144 is preferably 25 
cross-linked blood, as discussed hereinbefore, which has 
leaked into this chamber, been heated, and solidified. 
Another preferred embodm . ent of a shift-journal bearing 
would include a shaft (not shown) extending through rotor 
46 and engaging respective sleeves on flow straightener 18 3o 
and diffuser 20. As well. the flow straightener and/or 
diffuser, or relevant portions thereof, may be made from a 
suitable material. such as zirconia. with the bearing surfaces 
beiig formed or machined directly into that material. In a 
similar manner, the bearing surfaces of bearing 121,130, or 
other bearings could be machined into a bearing mount 35 
component. 
To avoid the problem of blood stagnation in the region of 
the bearing. several bearing washing configurations. using 
directed blood flow or pump differential pressures, may also 
be used as part of the present invention. Referring to FIG. 3, 40 
there is shown a means for using a pump pressure Weren- 
tial for washing bearing 150 which includes shaft 152 and 
journal sleeve 153. High pressure region 154 produces a 
blood flow through passage 156 to wash bearing 150 and 
exit to lower pressure region 158. Thus, Mood is prevented 45 
from stagnating behind bearing 150. 
Another bearing embodiment (not shown) would include 
a pressure fed journal bearing to form a hydrodynamic film 
that supports the shaft and loads so that the bearing surfaces 
do not touch. Shaft 152 would be slightly undersize with 50 
resped to a journal sleeve for th is  purpose. A pressure fed 
flow passage may be directed through such a hydrodynamic 
journal bearing from a high pressure region 154 to a low 
pressure region 158. 
which includes a producing bend 160 in pump housing 12. 
This bend places bearing 162 in a high velocity flow area 
Blood flow through bend 160 washes the bearing members, 
which include a male portion 164 and mating member 166. 
Other configurations for this type arrangement may be used, 
but the general principle is as described. The flow straight- 
ener is removed in th is  embodiment, but may be included in 
another e m w e n t  where it does not necessarily need to 
act as a bearing support. 
FIG. 6D and 6E illustrate yet another bearing arrangement 
embodiment. In this embodiment, a bearing shaft 170 65 
extends through journal sleeve 172. Bearing shaft 170 has an 
oblong or substantially oval transverse cross-section, as 
mG. 6C illustrates another bearing washing method 55 
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shown in FIG. 6E. This configuration produces flow paths 
174 through journal sleeve 172 so as to flush the bearing and 
prevent blood stagnation. Shaft 170 could also be fluted so 
as to have spirals, slots, or other flow paths 174 formed 
along its periphery within sleeve 172. 
FIG. 6F shows a bearing configuration wherein rotor 46 
is cantilevered with respect to diffuser 20 using two bearings 
180 and 182. Shaft 184 extends b e e e n  the two bearings. 
Each bearing includes a rotating ball surface, 186 and 188. 
mating with a socket surface 198 and 192, respectively. 
Socket surfaces 190 and 192 are formed in ceramic material 
sleeves 194 and 1%. respectively. The bearings are “zero 
tolerance” bearings. Thus, either the shaft 184 which runs 
through diffuser 20 or the diffuser 20 itself must provide a 
takeup mechanism that keeps each ball surface 186 and 188 
,tightly engaged with a respective socket surfaces 199 and 
192. For this pmpose, diffuser 20 could be made of com- 
pressible material. Alternatively, diffuser 20 could receive 
injection molding around sleeves 194 or 1%. 
As another alternative, either a passive. active, or a 
combination passive-active magnetic bearing suspension 
system (not shown) could be used to rotatably mount rotor 
46. For this embodiment, the rotor 46 would be axially 
positioned and/or bearing surfaces would be suspended with 
respect to each other using magnetic force. 
The method of the present invention is illustrated in FIG. 
8 which shows a test matrix for optimizing the pump 
parameters which are believed to afFect hemolysis. This 
method enables optimization of pump parameters as dis- 
cussed hereinafter with a minimum number of tests. 
Although t h i s  matrix is designed for a blood pump with no 
inducer or flow straightener, it is believed that the method of 
the present invention is clearly illustrated with th is  example. 
and may be used to improve most other blood pump designs 
with respect to hemolysis, thrombus, pump efficiency, cost,. 
and other important factors. Using this approach, it is 
possible to thoroughly investigate many parameters in an 
organized, methodical approach to achieve highly desired 
goals, such as optimum pump performance and minimum 
hemolysis. 
To apply this method, it was first necessary to identify the 
pump parameters that were believed to afFe.ct hemolysis. The 
variables are listed at the headings of the test matrix, and 
include blade tip shape, radial clearance, axial clearance. 
number of blades, and impeller length. To judge effectively 
the impact of each variable on hemolysis, the method of the 
present invention requires that all pump dimensions be held 
constant while only one variable is changed. As shown in the 
matrix of FIG. 8,16 Merent tests are used. Preferably, each 
test is made at least three Werent times to provide statistical 
results and check consistency. 
The information learned in initial tests is used later in the 
matrix. For example, tests 1 and 2 compare the effects of flat 
and round blade tip geometries. The least hemolytic of the 
two is then used in all remaining tests. If there is no 
statistically significant difference. then the result that pro- 
vides superior hydrodynamic pedormance is used. If there is 
no hydrodynamic difference, then the least expensive 
parameter to manufacture is used. Test conditions are con- 
stant for each parameter. AU tes ts  were made using bovine 
blood at a flow of 5 literdrain against 100 mm Hg. The 
duration of each test was 20 minutes. The pump Circulates 
blood through a test loop having a 500 cc blood reservoir 
which was conveniently a 500 cc blood bag. The 500 cc 
blood bag is preferably changed after each version of each 
parameter is tested. 
In order to compare various impeller and stator blade 
geometries within a reasonable time period, a stereolithog- 
raphy technique was used to quickly realize the complex 
shapes. This technique relies on a laser beam that scans the 
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surface of a liquid acrylic polymer. The polymer hardens 
under the infiuence of the laser, and layer by layer a solid 
shaped is formed from the liquid surface. 
is used. This is defined as the amount of hemoglobin 
100 mm Hg. In equation form: 
by those skilled in the art that various changes in the size, 
shape, materials, as well as in the details of the illustrated 
construction. may be made without departing from the spirit 
of the invention. TO compare hemolysis results, an index of hemolysis (IH) 
what is is: 
liberated in &rams loo liters Of Pumped against 1. A method for Optimizing each of a of blood 
pump configuration parameters, comprising the following 
1M) (1) steps: 
IH = AHb X V X  (1 - H?) X 
where: 
IH equals amount of hemoglobin liberated in grams per 
Ht is the hematocrit in decimal percent; 
V is the blood volume in liters; 
AHb is the mount of hemoglobin liberated in a fixed time 
Flow is the flow rate in liters per minute; and 
Time is the total time in minutes at that flow rate. 
The final results are seen in the matrix of FIG. 8. Other 
more detailed factors of testing in accord with the method of 
this invention are discussed more thoroughly in the articles 
which have been named previously and incorporated herein 
by reference. 
As to manufacturing and usage considerations, pump 10 
is preferably manufactured using materials designed to be 
buoyant inside the body to make the completed pump 
neutrally buoyant or approximately neutrally buoyant. This 
minimizes stress on stitches or other means used to position 
the pump within the body. Thus, the rotor. rotor blades, 
and/or other components may be made with a lightweight 
material having sufficient thickness to produce a buoyant 
effect. 
Pump 10 has numerous uses as a blood pump, including 
use as a portable blood pumping unit for field service. Pump 
10 may also be used for other clinical applications involving 
other fluids. It could, for instance. be used in  a compact 
heart-lung machine. Due to the small volume and size of 
pump 10, it can be placed close to a patient to minimize 
shock caused when initiating blood pump operation using a 
saline solution. Larger pumps, with larger volume, may be 
awkward to move close by a patient to eliminate this shock 
Thus. the blood pump of the present invention, particu- 
larly when optimized using the method of the present 
invention. has many advantages over the prior art. For 
instance. there are no blood seals which require bearing 
purge systems. No Hall Effect sensors are required which 
may tend to limit motor control reliability due to their 
complexity. As well, pump 10 provides low power consump 
tion and very low levels of hemolysis. 
The foregoing disclosure and description of the invention 
is illustrative and explanatoq thereof. It will be appreciated 
100 liters of blood pumped against 100 mm Hg; 
period in grandliter; 
selecting a plurality of blood pump configuration param- 
eters for determining a corresponding effect of each 
parameter on the damage level to blood: 
determining at least one variation of each of said blood 
pump configuration parameters to be optimized; 
selecting a first blood pump configuration parameter to be 
circulating blood through a blood pump; 
determining blood damage to said blood; 
changing said first blood pump configuration parameter to 
said at least one variation of said blood pump configu- 
ration parameters while retaining al l  remaining blood 
pump configuration parameters treehanged; 
circulating blood through said blood pump after said 
change to said first blood pump configuration param- 
eter; 
determining blood damage to said blood after said 
change; 
selecting an optimal variation of said fmt blood pump 
configuration parameter which reduces said blood dam- 
age level to a minimum; 
wherein said step of d e e g  blood damage further 
comprises: 
determining an index of hemolysis such that 
10 
15 
optimized; 
*O 
25 
30 
35 
IH = AHb x V x (1 - tit) x wow'~T-t , 
where: 
IH equals amount of hemoglobin liberated in grams per 
Ht is the hematocrit in decimal percent; 
V is the blood volume in liters; 
AHb is the amount of hemoglobin liberated in a fixed time 
Flow is the flow rate in liters per minute; and 
Time is the total time in minutes at that flow rate. 
40 
100 liters of blood pumped against 100 mm Hg; 
45 
period in gramdliter. 
* * * * *  
